Cargando…
Artificial intelligence in diabetes management: Advancements, opportunities, and challenges
The increasing prevalence of diabetes, high avoidable morbidity and mortality due to diabetes and diabetic complications, and related substantial economic burden make diabetes a significant health challenge worldwide. A shortage of diabetes specialists, uneven distribution of medical resources, low...
Autores principales: | Guan, Zhouyu, Li, Huating, Liu, Ruhan, Cai, Chun, Liu, Yuexing, Li, Jiajia, Wang, Xiangning, Huang, Shan, Wu, Liang, Liu, Dan, Yu, Shujie, Wang, Zheyuan, Shu, Jia, Hou, Xuhong, Yang, Xiaokang, Jia, Weiping, Sheng, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591058/ https://www.ncbi.nlm.nih.gov/pubmed/37788667 http://dx.doi.org/10.1016/j.xcrm.2023.101213 |
Ejemplares similares
-
A deep learning system for detecting diabetic retinopathy across the disease spectrum
por: Dai, Ling, et al.
Publicado: (2021) -
Artificial intelligence in inflammatory bowel disease: current status and opportunities
por: Li, Ji, et al.
Publicado: (2020) -
Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China
por: Liang, Yebei, et al.
Publicado: (2021) -
FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China
por: Liu, Dan, et al.
Publicado: (2021) -
Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
por: Wu, Liang, et al.
Publicado: (2020)